Annual SGA
$184.26 M
+$31.41 M+20.55%
December 31, 2023
Summary
- As of February 12, 2025, CORT annual SGA is $184.26 million, with the most recent change of +$31.41 million (+20.55%) on December 31, 2023.
- During the last 3 years, CORT annual SGA has risen by +$78.93 million (+74.94%).
- CORT annual SGA is now at all-time high.
Performance
CORT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$73.75 M
+$6.81 M+10.17%
September 30, 2024
Summary
- As of February 12, 2025, CORT quarterly SGA is $73.75 million, with the most recent change of +$6.81 million (+10.17%) on September 30, 2024.
- Over the past year, CORT quarterly SGA has increased by +$17.48 million (+31.06%).
- CORT quarterly SGA is now at all-time high.
Performance
CORT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
$1.81 B
+$141.82 M+8.49%
September 30, 2024
Summary
- As of February 12, 2025, CORT TTM SGA is $1.81 billion, with the most recent change of +$141.82 million (+8.49%) on September 30, 2024.
- Over the past year, CORT TTM SGA has increased by +$1.62 billion (+843.71%).
- CORT TTM SGA is now at all-time high.
Performance
CORT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CORT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.6% | +31.1% | +843.7% |
| 3 y3 years | +74.9% | +74.2% | +1085.2% |
| 5 y5 years | +126.7% | +74.2% | +1085.2% |
CORT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.6% | at high | +128.4% | at high | +203.8% |
| 5 y | 5-year | at high | +83.6% | at high | +188.4% | at high | +809.8% |
| alltime | all time | at high | +6943.5% | at high | >+9999.0% | at high | +236.9% |
Corcept Therapeutics Incorporated Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $73.75 M(+10.2%) | $244.10 M(+13.2%) |
| Jun 2024 | - | $66.94 M(+19.0%) | $215.62 M(+12.3%) |
| Mar 2024 | - | $56.27 M(+19.3%) | $191.96 M(+4.2%) |
| Dec 2023 | $184.26 M(+20.6%) | $47.15 M(+4.2%) | $184.26 M(+2.7%) |
| Sep 2023 | - | $45.26 M(+4.6%) | $179.43 M(+6.0%) |
| Jun 2023 | - | $43.28 M(-10.9%) | $169.33 M(+3.3%) |
| Mar 2023 | - | $48.56 M(+14.7%) | $163.86 M(+7.2%) |
| Dec 2022 | $152.85 M(+24.9%) | $42.32 M(+20.4%) | $152.85 M(+7.0%) |
| Sep 2022 | - | $35.16 M(-7.0%) | $142.81 M(+3.4%) |
| Jun 2022 | - | $37.81 M(+0.7%) | $138.18 M(+6.0%) |
| Mar 2022 | - | $37.55 M(+16.3%) | $130.40 M(+6.6%) |
| Dec 2021 | $122.36 M(+16.2%) | $32.28 M(+5.7%) | $122.36 M(+5.7%) |
| Sep 2021 | - | $30.53 M(+1.7%) | $115.77 M(+3.6%) |
| Jun 2021 | - | $30.03 M(+1.8%) | $111.76 M(+4.2%) |
| Mar 2021 | - | $29.51 M(+14.8%) | $107.30 M(+1.9%) |
| Dec 2020 | $105.33 M(+4.9%) | $25.70 M(-3.1%) | $105.33 M(-1.3%) |
| Sep 2020 | - | $26.52 M(+3.7%) | $106.76 M(+2.2%) |
| Jun 2020 | - | $25.57 M(-7.1%) | $104.48 M(+0.9%) |
| Mar 2020 | - | $27.54 M(+1.5%) | $103.50 M(+3.1%) |
| Dec 2019 | $100.36 M(+23.5%) | $27.13 M(+11.9%) | $100.36 M(+5.9%) |
| Sep 2019 | - | $24.25 M(-1.4%) | $94.78 M(+3.2%) |
| Jun 2019 | - | $24.59 M(+0.8%) | $91.85 M(+5.3%) |
| Mar 2019 | - | $24.39 M(+13.1%) | $87.24 M(+7.3%) |
| Dec 2018 | $81.29 M(+30.2%) | $21.56 M(+1.2%) | $81.29 M(+6.2%) |
| Sep 2018 | - | $21.31 M(+6.6%) | $76.52 M(+6.7%) |
| Jun 2018 | - | $19.98 M(+8.4%) | $71.69 M(+8.9%) |
| Mar 2018 | - | $18.44 M(+9.8%) | $65.82 M(+5.5%) |
| Dec 2017 | $62.42 M(+38.0%) | $16.80 M(+2.0%) | $62.42 M(+8.8%) |
| Sep 2017 | - | $16.47 M(+16.7%) | $57.38 M(+10.7%) |
| Jun 2017 | - | $14.11 M(-6.1%) | $51.84 M(+4.0%) |
| Mar 2017 | - | $15.04 M(+27.9%) | $49.85 M(+10.2%) |
| Dec 2016 | $45.24 M(+22.4%) | $11.76 M(+7.6%) | $45.24 M(+6.8%) |
| Sep 2016 | - | $10.93 M(-9.8%) | $42.34 M(+4.0%) |
| Jun 2016 | - | $12.12 M(+16.2%) | $40.70 M(+7.3%) |
| Mar 2016 | - | $10.43 M(+17.7%) | $37.93 M(+2.6%) |
| Dec 2015 | $36.95 M(+5.8%) | $8.86 M(-4.6%) | $36.95 M(+2.3%) |
| Sep 2015 | - | $9.29 M(-0.5%) | $36.13 M(+0.5%) |
| Jun 2015 | - | $9.34 M(-1.2%) | $35.94 M(+4.0%) |
| Mar 2015 | - | $9.45 M(+17.5%) | $34.56 M(-1.0%) |
| Dec 2014 | $34.92 M(+11.8%) | $8.04 M(-11.6%) | $34.92 M(+1.5%) |
| Sep 2014 | - | $9.10 M(+14.3%) | $34.39 M(+5.9%) |
| Jun 2014 | - | $7.96 M(-18.8%) | $32.47 M(-0.6%) |
| Mar 2014 | - | $9.80 M(+30.4%) | $32.66 M(+4.6%) |
| Dec 2013 | $31.24 M | $7.52 M(+4.7%) | $31.24 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | $7.18 M(-12.0%) | $30.20 M(+5.2%) |
| Jun 2013 | - | $8.16 M(-2.7%) | $28.72 M(+9.2%) |
| Mar 2013 | - | $8.38 M(+29.3%) | $26.31 M(+3.5%) |
| Dec 2012 | $25.41 M(+124.3%) | $6.48 M(+13.8%) | $25.41 M(+14.4%) |
| Sep 2012 | - | $5.69 M(-1.0%) | $22.21 M(+12.6%) |
| Jun 2012 | - | $5.75 M(-23.2%) | $19.73 M(+18.5%) |
| Mar 2012 | - | $7.49 M(+128.1%) | $16.64 M(+46.9%) |
| Dec 2011 | $11.33 M(+33.5%) | $3.28 M(+2.3%) | $11.33 M(+1.1%) |
| Sep 2011 | - | $3.21 M(+20.4%) | $11.21 M(+13.4%) |
| Jun 2011 | - | $2.67 M(+22.6%) | $9.88 M(+8.7%) |
| Mar 2011 | - | $2.17 M(-31.2%) | $9.09 M(+7.1%) |
| Dec 2010 | $8.49 M(+44.4%) | $3.16 M(+68.0%) | $8.49 M(+25.9%) |
| Sep 2010 | - | $1.88 M(+0.5%) | $6.74 M(+5.3%) |
| Jun 2010 | - | $1.87 M(+18.8%) | $6.40 M(+5.3%) |
| Mar 2010 | - | $1.57 M(+11.4%) | $6.08 M(+3.4%) |
| Dec 2009 | $5.88 M(+2.3%) | $1.41 M(-8.4%) | $5.88 M(-0.3%) |
| Sep 2009 | - | $1.54 M(-0.2%) | $5.90 M(-2.1%) |
| Jun 2009 | - | $1.55 M(+12.5%) | $6.02 M(+2.3%) |
| Mar 2009 | - | $1.37 M(-4.2%) | $5.89 M(+2.5%) |
| Dec 2008 | $5.75 M(+18.1%) | $1.43 M(-14.0%) | $5.75 M(-5.2%) |
| Sep 2008 | - | $1.67 M(+18.3%) | $6.06 M(+8.5%) |
| Jun 2008 | - | $1.41 M(+14.4%) | $5.58 M(+12.4%) |
| Mar 2008 | - | $1.23 M(-29.4%) | $4.96 M(+2.0%) |
| Dec 2007 | $4.87 M(-3.5%) | $1.75 M(+46.6%) | $4.87 M(+14.2%) |
| Sep 2007 | - | $1.19 M(+50.3%) | $4.26 M(-4.7%) |
| Jun 2007 | - | $793.00 K(-30.1%) | $4.47 M(-8.0%) |
| Mar 2007 | - | $1.14 M(-0.6%) | $4.86 M(-3.6%) |
| Dec 2006 | $5.04 M(+23.5%) | $1.14 M(-18.5%) | $5.04 M(+3.1%) |
| Sep 2006 | - | $1.40 M(+18.6%) | $4.89 M(+9.9%) |
| Jun 2006 | - | $1.18 M(-10.2%) | $4.45 M(+2.8%) |
| Mar 2006 | - | $1.32 M(+32.8%) | $4.33 M(+5.9%) |
| Dec 2005 | $4.08 M(-9.1%) | $991.00 K(+3.2%) | $4.08 M(-5.2%) |
| Sep 2005 | - | $960.00 K(-9.5%) | $4.31 M(-4.4%) |
| Jun 2005 | - | $1.06 M(-1.1%) | $4.51 M(-1.4%) |
| Mar 2005 | - | $1.07 M(-11.8%) | $4.57 M(+1.8%) |
| Dec 2004 | $4.49 M(-18.7%) | $1.22 M(+4.8%) | $4.49 M(+37.1%) |
| Sep 2004 | - | $1.16 M(+3.1%) | $3.28 M(+20.0%) |
| Jun 2004 | - | $1.13 M(+13.3%) | $2.73 M(+23.0%) |
| Mar 2004 | - | $993.00 K(+61.8%) | $2.22 M(+43.6%) |
| Sep 2003 | - | $613.90 K(-0.1%) | $1.55 M(+65.8%) |
| Jun 2003 | - | $614.60 K(+92.7%) | $933.50 K(+192.7%) |
| Mar 2003 | - | $318.90 K | $318.90 K |
| Dec 2002 | $5.53 M(+111.4%) | - | - |
| Dec 2001 | $2.62 M | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual SGA?
- What is the all time high annual SGA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual SGA year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly SGA?
- What is the all time high quarterly SGA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly SGA year-on-year change?
- What is Corcept Therapeutics Incorporated TTM SGA?
- What is the all time high TTM SGA for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM SGA year-on-year change?
What is Corcept Therapeutics Incorporated annual SGA?
The current annual SGA of CORT is $184.26 M
What is the all time high annual SGA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual SGA is $184.26 M
What is Corcept Therapeutics Incorporated annual SGA year-on-year change?
Over the past year, CORT annual SGA has changed by +$31.41 M (+20.55%)
What is Corcept Therapeutics Incorporated quarterly SGA?
The current quarterly SGA of CORT is $73.75 M
What is the all time high quarterly SGA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly SGA is $73.75 M
What is Corcept Therapeutics Incorporated quarterly SGA year-on-year change?
Over the past year, CORT quarterly SGA has changed by +$17.48 M (+31.06%)
What is Corcept Therapeutics Incorporated TTM SGA?
The current TTM SGA of CORT is $1.81 B
What is the all time high TTM SGA for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM SGA is $1.81 B
What is Corcept Therapeutics Incorporated TTM SGA year-on-year change?
Over the past year, CORT TTM SGA has changed by +$1.62 B (+843.71%)